Skip to content

LV ENDOCRINE

Active Private limited companyfounded 2023active for 3 yearsAvenue du Centenaire 39, 4053 ChaudfontaineKBO/BCE: BE 0798.796.285

Lifetime

3 annual accounts with figures on one time axis
peak of €97,303 in 2025
€97,303▲ 58.9%
peak of €67,205 in 2025
€67,205▲ 90.5%
peak of €159,085 in 2025
€159,085▲ 73.1%
€45,486▼ 7.7%
Board1 name since 2023
1 director
Documentsfilings and deeds
13-07-202618 days before the deadline
2025micro format
Gross margin from €61,218 to €97,303Result from €35,280 to €67,205Equity from €91,879 to €159,085Cash from €136,660 to €201,427

Key points

from the 2025 annual accounts

Equity

€159,085 ▲ 73.1%
€91,9002024€159,0002025

Equity rose in 2025 from €91,879 to €159,085.

Turnover

≈ €220,000 estimated

The micro format states no turnover.

Liquidity

4.44 was 2.78 in 2024

Short-term debts fell from €49,261 to €45,486.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 39,332 companies had the same profile as LV ENDOCRINE has now. Each dot stands for 99 companies, two years later.

95.7%
were still trading
2.4%
stopped another way
1.8%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 39,332 companies, not a prediction for LV ENDOCRINE. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 23-02-2023
  • founderdeed of 27-02-2023
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0798796285
Incorporation Founding capital of €2,500 · Founded by (comparant constituant) · (director) and (director) appointed · published on 27-02-2023 · Gazette deed
All 9 events

Comparable companies

same main activity, similar in size and age
Company
LV ENDOCRINE Chaudfontaine €204,571 €97,303 77.8% -
BLSMU Chaudfontaine €214,708 €93,866 88.5% -
ThDerm Liège €206,611 €103,901 15.8% -
ZH MEDICAL Liège €184,263 €101,228 63.7% -
Gynecare SRL Modave €183,427 €98,106 82.4% -
AL Van Massenhove Héron €212,665 €110,003 55.2% -
Docteur Emilie GODINAS Esneux €193,848 €110,096 37.4% -

These companies have the same main activity as LV ENDOCRINE: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €183,000 and €215,000, founded between 2022 and 2023.

Official details

Source: KBO
Status
Active since 23-02-2023Normal situation
Activity
Specialist medical practiceNACE 86220and 1 other
Establishment unit
2.345.134.8514053 Chaudfontaine, since 23-02-2023
Financial year end
31 December
Peppol
Reachable since 10-12-2025
Company details

Annual accounts 2025

€204,571▲ 44.9%
Filing
Filed on 13-07-2026, 18 days before the end of the filing period
Financials

Insights on LV ENDOCRINE

LV ENDOCRINE files the micro format. That format states no turnover. The gross margin rose from €84,886 in 2023 to €97,303 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about LV ENDOCRINE

What is the company number of LV ENDOCRINE?
The company number of LV ENDOCRINE is 0798.796.285. The VAT number is the same number with BE in front: BE 0798.796.285.
Where is LV ENDOCRINE based?
The registered office is at Avenue du Centenaire 39, 4053 Chaudfontaine.Company details
What does LV ENDOCRINE do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of LV ENDOCRINE?
LV ENDOCRINE is a private limited company (BV).
When was LV ENDOCRINE founded?
LV ENDOCRINE was founded on 23-02-2023.
Is LV ENDOCRINE still active?
Yes, LV ENDOCRINE is an active enterprise in the KBO register.
What is the turnover of LV ENDOCRINE?
The turnover in financial year 2025 is about €220,000. This figure is estimated from the gross margin of €97,303 and 33 comparable companies (NACE 862). It probably lies between €160,000 and €270,000.Financials
Is LV ENDOCRINE profitable?
In financial year 2025, LV ENDOCRINE made a profit of €67,205.
Where can I find the annual accounts of LV ENDOCRINE?
LV ENDOCRINE filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of LV ENDOCRINE due?
LV ENDOCRINE must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.